Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

Sensitisation to Ambrosia in Switzerland : a public health threat on the wait
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID 533240
Author(s) Ackermann-Liebrich, U.; Schindler, C.; Frei, P.; Probst-Hensch, N. M.; Imboden, M.; Gemperli, A.; Rochat, T.; Schmid-Grendemeier, P.; Bircher, A. J.
Author(s) at UniBasel Frei, Patrizia
Probst Hensch, Nicole
Schindler, Christian
Ackermann-Liebrich, Ursula A.
Year 2009
Title Sensitisation to Ambrosia in Switzerland : a public health threat on the wait
Journal Swiss medical weekly
Volume 139
Number 5-6
Pages / Article-Number 70-5
Keywords allergy, Ambrosia, Artemisia, hay fever, cross-reactivity, sensitisation
Mesh terms Adult; Ambrosia, immunology; Artemisia, immunology; Asthma, epidemiology; Cross Reactions, immunology; Humans; Immunization; Immunoglobulin E, immunology; Middle Aged; Public Health; Rhinitis, Allergic, Seasonal, epidemiology; Switzerland, epidemiology
Abstract BACKGROUND: Ambrosia artemisiifolia (short name = Ambrosia common ragweed) pollen is a potent allergen and has recently been found in Switzerland, spreading from the southwest of the country. The aim of this study is to describe Ambrosia sensitisation rates in the population-based SAPALDIA cohort (Swiss Study on Air Pollution And Lung Diseases In Adults) and to test whether an increase in these rates could be observed. METHODS: Among the 6345 participants from 8 areas who provided blood samples in 1991 and 2002, 5823 had valid results for specific IgE against common inhalant allergens tested with Phadiatop. In 2002 Ambrosia sensitisation was measured and positive tests were analysed for Artemisia vulgaris (mugwort). Blood samples taken in 1991 in Ticino and Geneva were also tested for Ambrosia. RESULTS: Sensitisation rate (Phadiatop) did not increase significantly between the two surveys and sensitisation was found in 30% of the participants. A proportion of 7.9% showed specific IgE to Ambrosia pollen. The sensitisation rate in Lugano and Geneva had not changed substantially since 1991. Among those sensitised to Ambrosia 82% also showed specific IgE against Artemisia, suggesting a high rate of cross-reactivity. Only 1.3% were sensitized to Ambrosia alone. The incidence of asthma or hay fever in participants with specific IgE to Ambrosia pollen was not higher than in the general study population. CONCLUSION: Currently Ambrosia pollen does not appear to be an important cause of inhalant allergies in Switzerland. Sensitisation rates are low and have not increased since 1991. Due to cross-reactivity Ambrosia sensitisation may be a consequence of primary sensitisation to Artemisia. Elimination of Ambrosia plants is nevertheless mandatory to avoid a future increase.
Publisher EMH
ISSN/ISBN 1424-7860
Full Text on edoc No
PubMed ID
ISI-Number WOS:000263252400004
Document type (ISI) Journal Article

MCSS v5.8 PRO. 0.370 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |